Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
I know Jamestown closes on June 1st...
When do we expect the 10Q..?
First gap at .03 then .90
Gonna be fireworks one day soon enough...
Quote:
When 10Q comes out I'm expecting some pumpage of Jamestown from CEO.
Stock is beaten down and due for a nice bounce.
Thank you kindly Janet...
THIS IS JUST THE START...
Mega rewards in store in the next weeks and months here with RXMD...
RXMD- 2018 Company Goals:
RXMD- Progressive Care, Inc. (OTCQB: RXMD)
2016 Net Revenue: $18.32M
2017 Net Revenue: $20.1M
Uplisted to OTCQB on 12/5/2017
The following are our strategic goals for 2018:
•Achieve 25,000 prescriptions filled in a single month by December 2018
Increase annual overall sales to $22 million
Secure additional 340B contracts and long-term care facility relationships
Further expansion into Palm Beach County
Achieve accreditation for non-sterile compounding
Achieve full enterprise profitability and earnings growth
Publish 2nd year of audited financial statements and leverage these statements to secure new investment opportunities for mergers and acquisitions
Opening more Pharmco Pharmacy Resource Centers in retirement and long term care communities.
Strengthening our tele-pharmacy platform
Closing Remarks
The strength of Progressive Care has always been in the hands of its employees and its shareholders. Without the loyalty and dedication of both, this Company would not be where it is today. We have thrived because of the unyielding support in the face of immense challenges and we know that we must never waver in our desire to always earn the trust that has been bestowed upon us. Thank you to all who believe in us and we look forward to delivering another phenomenal year.
Yep... Ducks are lining up to score...
Power good stuff we have a $3.00 stock in subpennies. Strong play chart is reflecting Bullish and building support levels. We are going to make bank. Great find!
RENNOVA HEALTH CONFIRMS INTENDED CLOSING DATE FOR ACQUISITION OF 85 BED HOSPITAL IN JAMESTOWN, TN AS JUNE 1, 2018
WEST PALM BEACH, Fla., May 14, 2018 (GLOBE NEWSWIRE) -- Rennova Health, Inc. (OTCQB: RNVA), (OTCQB: RNVAW) (“Rennova” or the “Company”), a vertically integrated provider of industry-leading diagnostics and supportive software solutions to healthcare providers that recently announced the acquisition of its second Rural Hospital, is pleased to announce it has confirmed June 1st, 2018 as the expected closing date for its acquisition of an 85 bed hospital in Jamestown Tennessee.
While closing is subject to customary regulatory approvals and closing conditions the Company believes these are all scheduled to complete timely. The hospital known as Tennova Healthcare - Jamestown, and its associated assets are being acquired from Community Health Systems, Inc. (NYSE: CYH). The transaction also includes a Jamestown based doctor’s practice and clinic.
“We look forward to completing the acquisition of what will be our second hospital in the same geographic location at the end of this month and focusing on the successful integration with our existing business” said Seamus Lagan, Chief Executive Officer of Rennova. “We also look forward to completing the previously announced spin-offs of AMSG and our technology division in coming months. We continue to believe this will create additional value and opportunity for our shareholders and create separate public companies, each of which can focus on its own strengths and operational plans. We believe we can quickly achieve a cash-flow positive position in our new hospital division within the next few months and this combined with the spin-offs as planned should remove the need for additional capital to operate our business thereafter.”
About Rennova Health, Inc.
Rennova provides industry-leading diagnostics and supportive software solutions to healthcare providers, delivering an efficient, effective patient experience and superior clinical outcomes. Through an ever-expanding group of strategic brands that work in unison to empower customers, we are creating the next generation of healthcare. For more information, please visit www.rennovahealth.com.
Forward-Looking Statements
This press release includes “forward-looking statements” within the meaning of the safe harbor provisions of the United States Private Securities Litigation Reform Act of 1995. Actual results may differ from expectations and, consequently, you should not rely on these forward-looking statements as predictions of future events. Words such as “expect,” “estimate,” “project,” “budget,” “forecast,” “anticipate,” “intend,” “plan,” “may,” “will,” “could,” “should,” “believes,” “predicts,” “potential,” “continue,” and similar expressions are intended to identify such forward-looking statements. These forward-looking statements involve significant risks and uncertainties that could cause the actual results to differ materially from the expected results. Additional information concerning these and other risk factors are contained in the Company’s most recent filings with the Securities and Exchange Commission. The Company cautions readers not to place undue reliance upon any forward-looking statements, which speak only as of the date made. The Company does not undertake or accept any obligation or undertaking to release publicly any updates or revisions to any forward-looking statements to reflect any change in their expectations or any change in events, conditions or circumstances on which any such statement is based, except as required by law.
Contacts:
Rennova Health
Sebastien Sainsbury, 561-666-9818
ssainsbury@rennovahealth.com
https://globenewswire.com/news-release/2018/05/14/1501784/0/en/RENNOVA-HEALTH-CONFIRMS-INTENDED-CLOSING-DATE-FOR-ACQUISITION-OF-85-BED-HOSPITAL-IN-JAMESTOWN-TN-AS-JUNE-1-2018.html
Yep... This is going to sink in sooner or later...
Progressive Care Reports 30% Increase in Year-over-Year Prescriptions Filled During April 2018Press Release |05/17/2018
MIAMI, May 17, 2018 (GLOBE NEWSWIRE) -- Progressive Care Inc. (OTCQB:RXMD), a personalized healthcare services and technology company, today announced that the company experienced continued year-over-year growth in its revenue and number of prescriptions filled in the month of April 2018.
Wholly-owned subsidiary PharmCo, LLC filled approximately 22,000 prescriptions during the month of April, which is an increase of 30% over the same month last year. This resulted in the generation of nearly $1.6 million in net revenues, which is an increase of 7% year-over-year.
Revenues and prescription counts continue to increase as the Company promotes its proactive patient engagement model to doctor’s offices and clinics who are looking to lower healthcare costs and provide quality service to their patients. Additionally, the company filled over $430,000 worth of prescriptions on behalf of 340B entities (not included in Net Revenues) in April, generating fees due to the pharmacy of approximately $18,000, which is over a 260% increase over the same month last year.
“We are proud to have experienced yet another month of significant growth in April. We are accustomed to aggressive formulary adjustments in April from insurance plans which generally places downward pressure on our revenue base,” said S. Parikh Mars, CEO of Progressive Care Inc. "We were able to offset this pressure through our unique ability to offer a full range of products and personalized suggested medication therapy adjustments as needed. This has allowed us to maintain patient and physician loyalty while also expanding our market share.”
“Progressive Care continues to experience reimbursement compression across the medication spectrum; however, revenue has continued to increase as a result of our dedicated sales efforts, ongoing medication diversification, and expansion of our service offerings,” added Mars.
Yep... Right you are Janet...
RXMD- From my years of Observation when stocks are being "Shorted" they have difficult time to recover.....
**Shorts keeps having the "Upper Hand" due to lack of Understanding mainly due to "OTC Mentality"..... That it is better to have Less share that Continue to go Up with a steady growth than having lots of shares that are Continuously being taken down!!!.....
In other words it is better to have 10,000 shares reaching $1,00 than having 1,000,000 shares at 0,001 with the illusion that it might go higher!!!.....
To Counter the Shorts: Selling low with the hope to get more shares it is Playing into Shorts hands!
Buying at the ask they cannot take the PPS Down!!!....
Straight talking Non-Sense... As Usual...
When the Green Wave hits this next week my guess is...
You'll be gone... Short stuff...
RXMD GOLD
Way to go Bolce...
Let's keep working RXMD pps upwards..!
Wouldn't be surprised to see RXMD close between 8 - 9 today...
2nd pharmacy finalization in June...since its staffed and fully running already revs will be elevated to above 35M early 2019...bringing the fair market cap based on P/S ration in this sector up and the pps fair market value based on ~500M OS shares to ~50 cents
We shall have our Victory Cyber...
And it all begins within the next two weeks...
Hang in there my friend...
FACTS BE KNOWN.. AS RNVA SHARE HOLDERS WE HAVE ONE HELL OF AN ADVANTAGE OVER OTHERS. REST ASSURED RNVA IS IN THE TOP 99% OF ALL THE OTC TICKERS OUT THERE, AND HERE IS WHY. NOT GOING TO MENTION NAMES, CAUSE YOU ALREADY KNOW WHO IM REFERRING TO AND I DONT WANT TO HAVE THIS POST DELETED AS OFF TOPIC.
You said HOLD, and this was going to be one of the BEST - and I held, with high hopes.
Right your are Times...
Wouldn't be surprised to see RXMD close between 8 - 9 today...
2nd pharmacy finalization in June...since its staffed and fully running already revs will be elevated to above 35M early 2019...bringing the fair market cap based on P/S ration in this sector up and the pps fair market value based on ~500M OS shares to ~50 cents
I agree but they ran this up to .26 and everybody did well...
With all the excellent News for RXMD why aren't they running it up to .26 again..? Yep... Don't get it...
Thank you kindly, my friend...
New Green Wave started today and will rush into the weekend...
I LIKE TO CALL THIS READING BETWEEN THE LINES ALMOST A MUST TRADING OTC... GREAT POINT ANGELOH!
"As the company grows its revenues it can reduce its debt. The lender knows this and incorporated a 50% right of first refusal in the Sabby Master agreement. This only happens when a lender is confident in the company's ability to increase revenue and decrease lender debt."
Thanks Janet...
Doesn't close Green after this Excellent News...
Really don't get it...
Pick it up tomorrow for next Green Wave into the weekend...
RXMD-Progressive Care Reports 30% Increase in Year-over-Year Prescriptions Filled During April 2018
MIAMI, May 17, 2018 (GLOBE NEWSWIRE) -- Progressive Care Inc. (RXMD), a personalized healthcare services and technology company, today announced that the company experienced continued year-over-year growth in its revenue and number of prescriptions filled in the month of April 2018.
Wholly-owned subsidiary PharmCo, LLC filled approximately 22,000 prescriptions during the month of April, which is an increase of 30% over the same month last year. This resulted in the generation of nearly $1.6 million in net revenues, which is an increase of 7% year-over-year.
Revenues and prescription counts continue to increase as the Company promotes its proactive patient engagement model to doctor’s offices and clinics who are looking to lower healthcare costs and provide quality service to their patients. Additionally, the company filled over $430,000 worth of prescriptions on behalf of 340B entities (not included in Net Revenues) in April, generating fees due to the pharmacy of approximately $18,000, which is over a 260% increase over the same month last year.
“We are proud to have experienced yet another month of significant growth in April. We are accustomed to aggressive formulary adjustments in April from insurance plans which generally places downward pressure on our revenue base,” said S. Parikh Mars, CEO of Progressive Care Inc. "We were able to offset this pressure through our unique ability to offer a full range of products and personalized suggested medication therapy adjustments as needed. This has allowed us to maintain patient and physician loyalty while also expanding our market share.”
“Progressive Care continues to experience reimbursement compression across the medication spectrum; however, revenue has continued to increase as a result of our dedicated sales efforts, ongoing medication diversification, and expansion of our service offerings,” added Mars.
For more information about Progressive Care, please visit the company’s website.
Connect and stay in touch with us on social media:
Progressive Care Inc.
https://www.facebook.com/ProgressiveCareUS/
https://twitter.com/ProgressCareUS
PharmCo, LLC
https://www.facebook.com/pharmcorx/
https://twitter.com/PharmCoRx
About Progressive Care, Inc.
Progressive Care Inc. (RXMD), through its PharmCo, LLC, is a South Florida health services organization and provider of prescription pharmaceuticals, compounded medications, provider of tele-pharmacy services, the sale of anti-retroviral medications, medication therapy management (MTM), the supply of prescription medications to long term care facilities, and health practice risk management.
Cautionary Statement Regarding Forward Looking Statements
Statements contained herein that are not based upon current or historical fact are forward-looking in nature and constitute forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. Such forward-looking statements reflect the Company’s expectations about its future operating results, performance and opportunities that involve substantial risks and uncertainties. These statements include but are not limited to statements regarding the intended terms of the offering, closing of the offering and use of any proceeds from the offering. When used herein, the words “anticipate,” “believe,” “estimate,” “upcoming,” “plan,” “target,” “intend” and “expect” and similar expressions, as they relate to Progressive Care Inc., its subsidiaries, or its management, are intended to identify such forward-looking statements. These forward-looking statements are based on information currently available to the Company and are subject to a number of risks, uncertainties, and other factors that could cause the Company's actual results, performance, prospects, and opportunities to differ materially from those expressed in, or implied by, these forward-looking statements.
Public Relations Contact:
Tory Patterson, CMW Media
Public Relations Consultant
Tory@cmwmedia.com
www.cmwmedia.com
Investor Relations Contact:
Armen Karapetyan, Progressive Care
Senior Advisor Business Development
Armen@progressivecareus.com
www.progressivecareus.com
www.pharmcopharmacy.com
GlobeNewswire•May 17, 2018
Another awesome Post my friend...
Yes PB... Health is Wealth...
Quote:
Get your rest PB, health is more important than anything else.
RSI, CMF, MF, MACD all trending up as accumulation continues. It never ceases to amaze me that so much discourse is involved with a less than one (1) penny per share stock of a company that will very soon close on a hospital purchased way under market value by a company that clearly has access to capital to support and grow its operations.
This is truly a no brainer. I have seen similar circumstances on OTC when companies did not have nearly the assets of RNVA to improve revenues. Everyone seems to be forgetting that ultimately it really comes down to revenues and forward P/E. Now that AS has been increased the company has the access to capital markets and regardless of the dilution this is what companies must have in order to grow since capital is necessary to stabilize revenues at this point. Look at it this way.
As the company grows its revenues it can reduce its debt. The lender knows this and incorporated a 50% right of first refusal in the Sabby Master agreement. This only happens when a lender is confident in the company's ability to increase revenue and decrease lender debt.
How do I know this? While active in corporate finance I constructed numerous business operating plans and assisted third party supporting documentation providers for LENDERS underwritings.
PPS will eventually adjust to forward P/E. That will occur after revenues stabilize and is where the .90 area gap will fill. This could also happen sooner but a lot depends on market absorption as the OS increases.
WOW... A most excellent Post my friend...
This is what dilution does to a stock but whats on the other side? Naysayers would have you believe the stock is worthless and you should sell immediately to minimize loss. Longs average down and believe the stock will rebound.
In the center is the company using shares to access capital. MMs are buying heavily discounted shares and selling those shares into the market. No need to sell short when lots of new heavily discounted shares are readily available to sell to retail.
This understandably leaves a lot of angry shareholders but if you really step back and consider what is going on its not difficult to set a strategy. Everyone is different but here is what works for me. I buy shares when I believe the company has a viable business operating plan. Generally, I look for undervalued stocks. Undervalued is important from my point of view since I consider what caused the company stock to be undervalued in the first place.
RNVA imo Is undervalued and has a viable business operating plan. I dont chase the stock up or down since my position is longer term. I dont panic sell either.
So what keeps me in the stock?
The company was very public in its need for AS increase and also RS and has outlined its strategy for growth. Its never been a secret and has been out in the open for months. At less then one cent per share the risk to me is worth staying where I currently am.
I do think MMs will continue selling discounted shares which will continue driving price action. I have not seen the flippers buying back on L2 yet so I assume that small movements up followed by morning dumps are MMs trying to move the market until 10Q and the June 1st closing. Nothing out of the ordinary there.
Watch for 1 plus million share buyers since those are the currently sidelined flippers and MMs. When you see them start buying it is a pretty safe bet the price will gap. Since MMs tend to use events as market triggers the timing becomes predictable. For traders wanting to maximize short-term profits (if I wanted to do this), I would not make entry until I saw large buys of 1 mil plus. I would then ride the gap on news and sell on a MACD crossover combined with CMF or MFI, RSI, VOLUME, etc indicators signaled a reversal.
Thats just me though and yes I do DD and use TA. Not saying if you dont that wrong or anything. I dont care what others do, I do what works for me.
So what are the risks (as I see them)
1. Continued selling by MMs of discounted shares will negatively impact PPS.
2. Amount of cash needed to stabilize cash flow is unknown
3. Length of time needed to stabilize cash flow unknown.
4. Toxic lending has not been refinanced (Sabby) and shareholders are completely at the mercy of those converted shares being sold into the market. Initially, the OS increase is probably the company allowing shares to enter the market in exchange for capitalization.
[Risk-balancedced with reward
1. Position is significant enough that with a stabilized cash flow/earnings tied to forward PE will increase PPS on quarterly reports over longer term means a strong return on invested capital.
2. Debt reduction and possibly a refinance of Sabby note could significantly impact company ability to shed toxic financing resulting in positive movements in PPS. Have to monitor CEO to see how he intends to grow the company.
3. Risk is that CEO could dump total AS then RS again. He has a track record of doing this so carefully watching how the company performs will make this either an excellent investment or a tragic investment. At this point, for me the risk is worth the reward.
Right you are E...
THE 10Q SHOWED AN OVERALL EVEN QUARTER, BUT NET REVENUE WAS A PLUS AS WAS THE OUTLOOK FOR THE SHORT TERM FRIENDS!
I UNDERSTAND THE MARKET'S REACTION THE PAST 2 DAYS, BUT COMMON SENSE ALWAYS SETTLES IN 3 DAYS LATER WHICH IS TOMORROW. (THURSDAY 051718)
OPTIMISM IS MY OUTLOOK. GREEN IS MY COLOR FOR RXMD MOVING FORWARD.
Have to agree with you there John...
What will Progressive Care look like in 18 months?
35 million in annual revenue
3 locations
Still struggling to be profitable
2.5M cash on hand
22,500,000 shares outstanding
Authorized shares left at 500,000,000
$4.85 price per share
Thanks again Jimmy...
Here is SOME DATA
RXMD IS ON A COURSE FOR SUCCESS, ON OTCQB and NASDAQ
HERES SOME JUICY 2018 NUMBERS W/O NEW LOCATION
24% Scripts increase compared to March 31, 2017
$300,000+ Net Revenue increase compared to March 31, 2017
$870,000+ 340B sales increase compared to March 31, 2017
Any idea when 1st Q Report might be out..?
Quote:
Patience needed here for sure, but first quarter of the year 2018 as a combined company for the entire period will be very nice to see soon. A baseline of revenue for the rest of the year, which should only grow as the weather gets warmer and they are producing more product to sell. Holding big time and waiting. GLTA FRTZ holders.
Sounds promising Doc...
Any idea on when we might get the News..?
Quote:
I think we will see nice info forthcoming on Beta testing of Sayphr and news on the Pilot Project, or other deals. From that April 30th tweet, likely next week or so.
What will be coming soon that will happen to jumpstart the co. back into an upward direction..?
Quote:
I'm on the same strategy boat with you. I think it has one more positive up swing in it before completely folding and/or there's possibly something "soon" that will happen to jumpstart the co. back into an upward direction.
Well, when's the last time OTTV was at .003..?
Quote:
I believe this is how its done: buy at .0005/7 and sell @ .003 or higher. not the reverse. It makes one much happier
So my friend... Are you gonna stick with OTTV and if so for how much longer..?
I'm on the verge of needing to make a decision here to hold, sell or try to average down. I would, as I believe some others here would as well, like to know if there might be any News coming in the next few weeks that might influence the PPS in a positive direction. Anyone..?
I Thank You in advance...
Changes related to the merger caused a small decrease in revenue for the Munzee crew (for the first quarter of 2018, compared to the first quarter in 2017). This is the first time $FRZT has ever reported close to half a million in revenues for one quarter, so this is a whole new ball game! Now that the merger is complete and they continue to create new revenue streams, it is very reasonable to expect that revenues will only increase moving forward.
Yep... And the new acquisition is already reporting 100K+ a month.
Cash as of end of March $1.2M
Best Quarter ever at $5.1M
Uplifting to Nasdaq in less than a year...
OTCQB has been beneficial and needs to be used more and better which RXMD is ready to make more effective through its IR (CMW)...
Should see benefits in next 90-120 days...
Yep... I did...
That would be a fast gain of 142% from here...
Could happen today or by or before this Friday close...
Fill the Gap to .019... RNVA $$$
Quote:
Anyone notice the monster gap above us @ .0191?
Yep... Gonna be an awesome Conference Call...
Let's get the Ask back to 9+
NEWS FLASH. COMPANY INCREASED ASSETS BY OVER $1.2 MILLION AND CASH EQUIVALENTS BY OVER $1.1 MILLION IN 1ST QUARTER 2018. SET RECORD FOR REVENUE AND SCRIPTS IN A QUARTER.
Yep...
NEWS FLASH. COMPANY INCREASED ASSETS BY OVER $1.2 MILLION AND CASH EQUIVALENTS BY OVER $1.1 MILLION IN 1ST QUARTER 2018. SET RECORD FOR REVENUE AND SCRIPTS IN A QUARTER. GROSS PROFIT DECREASED BY 8% UNFORTUNATELY. LOSS REPORTED WAS FROM SHARES ISSUED FOR ACQUISITION PROCEEDS AND BONUSES, OTHERWISE BREAKEVEN QUARTER.
NOW FOR OLD NEWS
Excuse me is there any SHARE distribution here that wasn't already reported in annual. It's funny to see how it gets strung out, like we didn't already know about it. It's laughable.
Old News FLASH, we got 636k debt in Feb 2018 for new 2nd location acquisition that is to be paid off with 14 million shares, only 6 million left, and they are not selling and haven't been for over a week because they too know this is going much higher in share price.
Another Old News FLASH, we got 280k debt way back in July 2016 for current location build out that was paid off with $130k cash and $150k worth of shares.
And in other OLD News the company issued 40 million shares for bonuses back in January 2018.
All previously reported in financial statements.
Yep... It's a commin...
RNVA - Targets $0.026 / $0.035 / $0.14
https://www.otcmarkets.com/stock/RNVA/profile
http://www.allotcbb.com/quote.php?symbol=RNVA
https://www.barchart.com/stocks/quotes/RNVA
https://www.stockscores.com/charts/charts/?ticker=RNVA
https://otcshortreport.com/company/RNVA
Yeppers...
RXMD NEWS
https://finance.yahoo.com/news/progressive-care-inc-reports-largest-120000822.html
Progressive Care Inc. (RXMD), a healthcare services and technology organization providing prescription pharmaceuticals, compounded medications, health risk management and tele-pharmacy services, today announced financial results for the quarter ending March 31, 2018, and provided an overview of recent operational highlights along with updates on the Company’s strategies. The Company dispensed a total of 64,000 prescriptions in Q1, a 24% increase over Q1 2017. Revenue for the month of March 2018 was the largest single month in the Company’s history, totaling $1.9 million.
First Quarter 2018 Key Highlights:
- Completion of 2017 Audited Financial Statements (2nd year)
- $1.9 million of revenue in March 2018, largest single month in company’s history
- 5-star pharmacy rating
- Over $5.1 million in revenue during first quarter 2018, largest single quarter in company’s history
- Over 66,000 prescriptions filled during first quarter 2018, a 24%
increase over the same period in 2017
- Increased number of prescriptions from Empower “U” 340B contract
- Completed expansion plans into Palm Beach County, Florida through acquisition of Touchpoint RX pharmacy
- Raised over $1.4million for 340B charitable organizations
- Development and deployment of our online prescription management solution
- Acceptance of cryptocurrencies as a payment source
- Licensed in the following states: Colorado, Connecticut, Florida, Georgia, Illinois, Nevada, New Jersey, New York, Pennsylvania, Texas, Utah, Arizona, Massachusetts
Most Excellent..!
First Quarter 2018 Key Highlights:
- Completion of 2017 Audited Financial Statements (2nd year with unqualified audit opinion)
- $1.9 million of revenue in March 2018, largest single month in company’s history
- 5-star pharmacy rating
- Over $5.1 million in revenue during first quarter 2018, largest single quarter in company’s history
- Over 66,000 prescriptions filled during first quarter 2018, a 24%
increase over the same period in 2017
- Increased number of prescriptions from Empower “U” 340B contract
- Completed expansion plans into Palm Beach County, Florida through acquisition of Touchpoint RX pharmacy
- Raised over $1.4million for 340B charitable organizations
- Development and deployment of our online prescription management solution
- Acceptance of cryptocurrencies as a payment source
- Licensed in the following states: Colorado, Connecticut, Florida, Georgia, Illinois, Nevada, New Jersey, New York, Pennsylvania, Texas, Utah, Arizona, Massachusetts
You're not kind... You're disappointed remember..?
I don't give any credence to your constant complaining here...
I think we all know what your downer game is here...
Yep... This too... caught my eye...
Looking good RXMD..!
2018: Net Cash provided from operating activities: $309,827
2017: Net Cash provided from operating activities: $(8,641)
Not bad eh??
Awesome news my friend...
Yes, live on the leeward side, Oahu, Hawaii...
RNVA dah kine my friend...
RNVA WINS CIGNA LAWSUIT ==>$10M IN CLAIMS THEY WILL RECOUP FROM CIGNA
https://www.rennovahealth.com/news-media/press-releases/detail/254/rennova-healths-labs-win-appeal-in-the-eleventh-circuit
READ THE ORIGINAL LAWSUIT WHICH SPECIFIES DAMAGES AND CLAIMS. CIGNA MUST PAY RNVA, AND THEY WILL PAY. THIS IS ALL PUBLIC RECORD FOLKS - VERIFIED AND LEGAL.
Wrong... again...
You're going to be mightily disappointed when RXMD Q1 comes in...
Sorry for you my friend...
Yep... Right again my friend...
Terms in 8k are spelled out -RNVA received $1m cash today and individual investor note is not due for repayment / conversion until September 09 2019. A very good deal for RNVA and the individual investor knows the shares will be trading much much higher by then.
Only ones who lose out, are those who do not buy / hold the stock here while it is cheap IMO
$RNVA
Green to end your sad day...
Expect more sadness tomorrow as RXMD with Q1 is gonna be even greener...
Ahh... don't be sad... Buy at opening bell tomorrow... You'll have a happy day...
Right you are PB...
Gonna be a mega-green move up soon...
GOOD NEWS OUT THEY CONFIRM TO CLOSE THE HOSPITAL ON JUNE 1. TOO MUCH GOOD STUFF ARE COMING OUR WAY.
RENNOVA HEALTH CONFIRMS INTENDED CLOSING DATE FOR ACQUISITION OF 85 BED HOSPITAL IN JAMESTOWN, TN AS JUNE 1, 2018
WEST PALM BEACH, Fla., May 14, 2018 (GLOBE NEWSWIRE) -- Rennova Health, Inc. (OTCQB: RNVA), (OTCQB: RNVAW) (“Rennova” or the “Company”), a vertically integrated provider of industry-leading diagnostics and supportive software solutions to healthcare providers that recently announced the acquisition of its second Rural Hospital, is pleased to announce it has confirmed June 1st, 2018 as the expected closing date for its acquisition of an 85 bed hospital in Jamestown Tennessee.
While closing is subject to customary regulatory approvals and closing conditions the Company believes these are all scheduled to complete timely. The hospital known as Tennova Healthcare - Jamestown, and its associated assets are being acquired from Community Health Systems, Inc. (NYSE: CYH). The transaction also includes a Jamestown based doctor’s practice and clinic.
“We look forward to completing the acquisition of what will be our second hospital in the same geographic location at the end of this month and focusing on the successful integration with our existing business” said Seamus Lagan, Chief Executive Officer of Rennova. “We also look forward to completing the previously announced spin-offs of AMSG and our technology division in coming months. We continue to believe this will create additional value and opportunity for our shareholders and create separate public companies, each of which can focus on its own strengths and operational plans. We believe we can quickly achieve a cash-flow positive position in our new hospital division within the next few months and this combined with the spin-offs as planned should remove the need for additional capital to operate our business thereafter.”
About Rennova Health, Inc.
Rennova provides industry-leading diagnostics and supportive software solutions to healthcare providers, delivering an efficient, effective patient experience and superior clinical outcomes. Through an ever-expanding group of strategic brands that work in unison to empower customers, we are creating the next generation of healthcare. For more information, please visit www.rennovahealth.com.
Forward-Looking Statements
This press release includes “forward-looking statements” within the meaning of the safe harbor provisions of the United States Private Securities Litigation Reform Act of 1995. Actual results may differ from expectations and, consequently, you should not rely on these forward-looking statements as predictions of future events. Words such as “expect,” “estimate,” “project,” “budget,” “forecast,” “anticipate,” “intend,” “plan,” “may,” “will,” “could,” “should,” “believes,” “predicts,” “potential,” “continue,” and similar expressions are intended to identify such forward-looking statements. These forward-looking statements involve significant risks and uncertainties that could cause the actual results to differ materially from the expected results. Additional information concerning these and other risk factors are contained in the Company’s most recent filings with the Securities and Exchange Commission. The Company cautions readers not to place undue reliance upon any forward-looking statements, which speak only as of the date made. The Company does not undertake or accept any obligation or undertaking to release publicly any updates or revisions to any forward-looking statements to reflect any change in their expectations or any change in events, conditions or circumstances on which any such statement is based, except as required by law.
Contacts:
Rennova Health
Sebastien Sainsbury, 561-666-9818
ssainsbury@rennovahealth.com
https://globenewswire.com/news-release/2018/05/14/1501784/0/en/RENNOVA-HEALTH-CONFIRMS-INTENDED-CLOSING-DATE-FOR-ACQUISITION-OF-85-BED-HOSPITAL-IN-JAMESTOWN-TN-AS-JUNE-1-2018.html
Yep... Could be coming out tomorrow...
MMEG NEWS
Quote: April 18, 2018
On March 29, 2018, Momentous CEO Kurt Neubauer executed an agreement with an outside accounting firm to prepare both the Year End 10K and upcoming First Quarter 10Q for filing...
https://finance.yahoo.com/news/momentous-entertainment-group-provides-10k-130608060.html?.tsrc=rss
My advice is... don't be caught without shares when RXMD Q1 Report comes out tomorrow...
Will trigger another Green Wave...
HAPPY MOTHER'S DAY... Blessed be our Mothers both here... and in Heaven...